SCANLY Home OCT
Notal Vision
FDA clearedwet AMDneovascular AMD
A patient-operated OCT device that scans the retina at home, with automated analysis of fluid biomarkers sent to the physician to monitor wet AMD between office visits.
- Company
- Notal Vision
- Category
- Home monitoring
- Reads
- OCT scans taken by the patient at home
- Built for
- Retina specialists monitoring patients with neovascular AMD
- Billing
- Check vendor (CPT codes not stated on vendor page)
- Regulatory
- FDA De Novo DEN230043 (granted May 15, 2024), product code SAX, 21 CFR 886.1600. Also designated a Breakthrough Device. · source
- Last verified
- 2026-10-07
DotAEye is independent of Notal Vision. Confirm indications, intended use, and clearance status with the manufacturer before clinical use.